{"result": "(\"entity\"<|>MELAS SYNDROME<|>EVENT<|>MELAS syndrome is the most common mitochondrial disorder, characterized by a heterogeneous phenotypic expression that significantly impacts nutritional status and often leads to gastrointestinal symptoms and multiple hospital admissions.)\n##\n(\"entity\"<|>GASTROSTOMY<|>EVENT<|>Gastrostomy is a medical procedure involving the placement of a feeding tube directly into the stomach, which in this case was performed to provide enteral nutrition for the patient.)\n##\n(\"entity\"<|>PATIENT<|>PERSON<|>The patient is an individual suffering from MELAS syndrome who underwent gastrostomy and received enteral nutrition to manage her condition and maintain nutritional status.)\n##\n(\"entity\"<|>NUTRITIONAL SUPPORT<|>EVENT<|>Nutritional support refers to the medical intervention of providing nutrition to patients who are unable to eat adequately, which in this case was achieved through enteral nutrition via PEG.)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a common complication associated with artificial nutrition, particularly in patients with MELAS syndrome, where insulin resistance and insulinopenia are prevalent.)\n##\n(\"relationship\"<|>PATIENT<|>MELAS SYNDROME<|>The patient is diagnosed with MELAS syndrome, which significantly affects her nutritional status and treatment compliance.<|>8)\n##\n(\"relationship\"<|>PATIENT<|>GASTROSTOMY<|>The patient underwent a gastrostomy to facilitate enteral nutrition due to her condition.<|>7)\n##\n(\"relationship\"<|>PATIENT<|>NUTRITIONAL SUPPORT<|>The patient received nutritional support through enteral nutrition to maintain her health and manage her MELAS syndrome.<|>9)\n##\n(\"relationship\"<|>NUTRITIONAL SUPPORT<|>GASTROSTOMY<|>Gastrostomy was performed to provide the necessary nutritional support for the patient.<|>8)\n##\n(\"relationship\"<|>PATIENT<|>DIABETES<|>The patient developed diabetes as a complication of her MELAS syndrome and the associated nutritional interventions.<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: en           Formula Eapecllica para\n                    GGPH( ,12 UVkg dia)               DM (0,38 UVkg dia)\n50\n---\n         Tras comprobar la buena tolerancia a la SNG de alimentación se decidió colocar\nuna gastrostomía endoscópica percutánea (PEG). Finalmente, la paciente fue dada de\nalta con dieta por vía oral libre y recomendaciones de gastroparesia, nutrición enteral\nsuplementaria continua con 1000cc en 12 horas (75% de los requerimientos) con una\nfórmula específica para diabetes e insulina glargina 6 UI antes de la nutrición. Asimismo,\nse recomendó que se administrara toda la medicación a través de la PEG.\n\n\n\n         En la primera revisión tras el alta, la paciente presentaba cifras de glucemia\ncontroladas con tendencia a la hipoglucemia y había ganado 2 kg. En la revisión a los\n6 meses la paciente había dejado de comer porque le provocaba náuseas y vómitos y\nhabía aumentado la dosis de nutrición artificial hasta completar los requerimientos. El\npeso había aumentado hasta 42,6 kg y no había vuelto a tener ingresos hospitalarios.\nAdemás, había recuperado la menstruación y suspendido la insulina porque mantenía\ncifras de glucemia normales solo con la fórmula específica para diabetes.\n\n\n\n         Su última analítica presentaba los resultados mostrados en la Tabla 6.\n\n\n\nTabla 6. Pruebas complementarias a los 6 meses tras la instauración del soporte nutricional\nartificial\n                                      Glucosa 99 mgldl (74-106)Urea 47 mgldl (15-46)\n                                        Creatinina 0.8 (0.5-1.1)\n                                     Proteinas 7.8 g/dL (5.7-8.2)\n                                     Magnesio 2 mg/dL (1.3-2.7)\n                                 Colesterol total 231 mg/dL (<200)\n                                   Trigliceridos 165 mg/dL (<200)Hierro 68mcgldL (50-170)\n                                             TSH 3.3 mcUlmL\n                                          Estradiol 54.4 pglmL\n                                          Lutropina 9.6 mUI/mL\n                                         Folitropina 3.6 mUl/mL\n                                 Prolactina (sin reposo) 511 mUl/mL\n                                       Insulina 6.9 uUl/mL (2-25)\n                                     Peptido C 2.64 ng/ml (1.1-4.4)\n                                Vitaminas liposolubles en rango de Ia\n                                                 normalidad\n                                       Albumina 4.5 g/dL (3.2-4.8)\n                                     Prealbumina 33 mg/dL (20-40)\n                                                                                             51\n---\n    Discusión\n             El síndrome de MELAS es la enfermedad mitocondrial más frecuente y tiene una\n    expresión fenotípica muy heterogénea, pero con evidente repercusión sobre el estado\n    nutricional. Los síntomas gastrointestinales son frecuentes y condicionan el cumpli-\n    miento del tratamiento, lo que conlleva múltiples ingresos. En este caso, la nutrición\n    enteral a través de PEG constituye un tratamiento que permite mantener a una pacien-\n    te normonutrida y cumplir con el tratamiento, lo que ha reducido los ingresos. Por otro\n    lado, la diabetes es una complicación frecuente de la nutrición artificial y en concreto\n    de este síndrome, donde confluyen dos mecanismos fisiopatológicos, la insulinorre-\n    sistencia e insulinopenia, y cuyo tratamiento principal es la dieta y el ejercicio. Por\n    ello, esta circunstancia representa una oportunidad para utilizar una fórmula específica\n    para diabetes como tratamiento de la misma.\n\n\n\n    Conclusiones\n             La nutrición enteral a través de PEG constituye, en este caso de síndrome de\n    MELAS, una herramienta de tratamiento para el control de la glucemia, el estado\n    nutricional y la cumplimentación del tratamiento de la enfermedad de base.\n\n\n\n52\n---\nBibliografía\n1.  Thorburn DR. Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis.\n2004;27(3):349-62.\n\n\n\n2.  Rahman S, Ecob R, Costello H, Sweeney MG, Duncan AJ, Pearce K, et al. Hearing in 44-45 year olds\nwith m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population\nbased cohort study. BMJ Open. 2012;2:e000411.\n\n\n\n3. Pia S, Lui F. Melas Syndrome. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018\n[citado 4 de diciembre de 2018]. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK532959/\n\n\n\n4. Niedermayr K, Pölzl G, Scholl-Bürgi S, Fauth C, Schweigmann U, Haberland\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}